SecBot SecBot
Institutional Cluster

AXGN

Axogen, Inc.
MIXED
Impact 5/10
Horizonweeks Processed3mo ago
Institutional cluster: 6 buyers, 4 sellers (mixed)
Actionable Insight ◆ Mixed

The strong buying by active managers Artemis and Nuveen signals conviction in Axogen's growth story post-earnings, but Wasatch's trimming and the absence of insider buying warrant caution. Monitor next quarter's 13F for whether these positions were held or sold, and watch for any insider open-market purchases to confirm the thesis.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$49.67
T+0 close · Aug 11, 2026 · via day close
Latest settled
−1.85%
T+60 · $48.75
Vs SPY
+3.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $49.67entry
  2. T+1 · 3mo ago −3.26%α −3.96% · $48.05
  3. T+5 · 3mo ago −1.49%α −1.05% · $48.93
  4. T+20 · 2mo ago −15.74%α −13.85% · $41.85
  5. T+60 · 12d ago −1.85%α +3.26% · $48.75

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A mixed institutional cluster in AXGN for Q2 2026 shows six buyers accumulating $87.1M in new positions, led by Artemis Investment Management (doubled to $64.5M) and Nuveen (doubled to $25.2M), while four sellers trimmed $2.9M, led by Wasatch Advisors trimming 30% of its stake. The buying cluster aligns with the company's strong Q2 earnings beat and raised guidance filed 14 days prior, but the lack of insider buying and the presence of a large seller (Wasatch) tempers conviction. The cluster is dominated by active asset managers, suggesting a shared thesis around accelerating Breast segment growth and expanding insurance coverage, but the 45-day reporting lag means positions may have already been adjusted.

Key Financial Metrics

Direction
accumulating
Buy Value
$107.7M
Sell Value
$2.9M
Net Flow
$84.2M

Institutional Positions

Net institutional flow: $84.2M

▲ Buyers (6)

InstitutionActionChangePosition ValueValue Δ
Artemis Investment ManagementDOUBLED+299.2%$64.5M$52.9M
NuveenDOUBLED+401.1%$25.2M$21.6M
Russell Investments GroupDOUBLED+261.5%$5.9M$4.7M
CitigroupDOUBLED+621.3%$4.2M$3.8M
Victory Capital ManagementADD+45%$7.1M$3.6M
Envestnet Asset ManagementADD+86.7%$844.0K$520.0K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Wasatch AdvisorsTRIM-30.2%$61.5M-$1.7M
Panagora Asset ManagementTRIM-57.2%$2.5M-$987.5K
Mml Investors ServicesTRIM-68.1%$458.0K-$254.6K
Exchange Traded ConceptsTRIM-29.4%$1.2M-$19.4K

Key Facts

  • 6 institutional buyers added $87.1M in net new AXGN positions in Q2 2026
  • Artemis Investment Management doubled its stake from $11.6M to $64.5M (+299% shares)
  • Nuveen more than quadrupled its position from $3.6M to $25.2M (+401% shares)
  • Wasatch Advisors trimmed 30% of its stake, reducing from $61.5M to $59.9M
  • Q2 2026 revenue of $69.7M (+23% YoY) beat consensus of $67.1M; full-year guidance raised to at least $279M
  • No open-market insider buying was detected in the window, weakening the signal

Financial Impact

6 institutional buyers accumulated $87.1M in new positions while 4 sellers reduced holdings by $2.9M, for net institutional buying of approximately $84.2M

institutional ownershipfloat

Risk Factors

  • 13F data is 45 days stale; positions may have been unwound since quarter-end
  • Wasatch Advisors, a top-3 holder, trimmed 30% of its stake, a potential red flag
  • No insider buying to corroborate the institutional cluster
  • GAAP net loss widened to -$0.03/share vs +$0.01 a year ago; adjusted EBITDA margin compressed to 12.1% from 16.3%

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-AXGN-2026-Q2

Track record

19 reports on AXGN

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +32.04% at T+20 after the Oct 1, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $55.78 settles Dec 15
  2. Nov 9, 20267d ago 8-K Bullish 5/10 Entry $50.64 settles Dec 8
  3. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $51.35 settles Dec 3
  4. Oct 28, 202619d ago 8-K Bullish 6/10 No price data
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $49.25 settles Nov 25
  6. Oct 2, 20266w ago SC 13G Neutral 4/10 Entry $37.22 to $49.37 ▲ +32.64% +35.11% vs SPY
  7. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $37.39 to $49.37 ▲ +32.04% +33.85% vs SPY
  8. Oct 1, 20266w ago Press Release Bullish 6/10 Entry $37.39 to $49.37 ▲ +32.04% +33.85% vs SPY
  9. Sep 10, 20269w ago 424B5 Mixed 6/10 Entry $42.16 to $36.13 ▼ −14.30% −16.17% vs SPY
  10. Sep 10, 20269w ago 8-K Bullish 7/10 Entry $41.85 to $36.18 ▼ −13.55% −15.67% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026